India  
 
NewsR.in

US Company Announces Trials For Coronavirus Vaccine In Australia

Video Credit: WJZ Baltimore - Duration: 00:25s - Published
US Company Announces Trials For Coronavirus Vaccine In Australia

US Company Announces Trials For Coronavirus Vaccine In Australia

A U.S. biotechnology company announced the start of human trials in Australia of a vaccine for the coronavirus with hopes of releasing a proven vaccine this year.


You Might Like

Related news from verified sources

US company begins vaccine trial on humans in Australia

US biotechnology company Novavax began injecting a coronavirus vaccine candidate into people in...
IndiaTimes - Published

Chinese coronavirus vaccine could be tested, manufactured in Canada

China's CanSino Biologics Inc, the company behind one of the few coronavirus vaccine candidates...
Reuters India - Published

Top Australian biotech firm CSL joins virus treatment race

Australia's biggest biotech company CSL Ltd said on Wednesday it will start trials for an antibody...
Reuters India - Published


Related videos from verified sources

Dr. Fauci Is 'Cautiously Optimistic' About Possibility Of COVID-19 Vaccine [Video]

Dr. Fauci Is 'Cautiously Optimistic' About Possibility Of COVID-19 Vaccine

Researchers working on a vaccine for the novel coronavirus have announced promising results in a very small drug trial. Biotech company Moderna said the first phase of trials for a COVID-19 vaccine..

Credit: Wochit     Duration: 00:32Published
'Moderna' vaccine shows promise in trial [Video]

'Moderna' vaccine shows promise in trial

Participants who received a COVID-19 vaccine by Moderna have developed antibodies against the virus. That's according to a press release by the biotech company.

Credit: KTNV Channel 13 Las Vegas     Duration: 00:33Published
The 5:30 A.M. Warrior Call: The FDA Approves Phase 2 Testing of Coronavirus Vaccine (5/8/2020) [Video]

The 5:30 A.M. Warrior Call: The FDA Approves Phase 2 Testing of Coronavirus Vaccine (5/8/2020)

Biotech company Moderna said it plans to start phase 2 trials with 600 participants shortly.

Credit: Entrepreneur     Duration: 35:48Published